Andreas Trojan

6PUBLICATIONS
28CO-AUTHORS
Epidemiological modellingPredictive and prognostic markersData qualityMusic therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 06, 2024
Impact of Electronic Patient-Reported Outcomes on Unplanned Consultations and Hospitalizations in Patients With Cancer Undergoing Systemic Therapy: Results of a Patient-Reported Outcome Study Compared With Matched Retrospective Data.

Andreas Trojan, Christian Kühne, Michael Kiessling

|Apr 04, 2024
Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes.

Andreas Trojan, Sven Roth, Ziad Atassi

|Aug 12, 2021
The Effect of Collaborative Reviews of Electronic Patient-Reported Outcomes on the Congruence of Patient- and Clinician-Reported Toxicity in Cancer Patients Receiving Systemic Therapy: Prospective, Multicenter, Observational Clinical Trial.

Andreas Trojan, Nicolas Leuthold, Christoph Thomssen

|Mar 17, 2021
Effect of Collaborative Review of Electronic Patient-Reported Outcomes for Shared Reporting in Breast Cancer Patients: Descriptive Comparative Study.

Andreas Trojan, Basil Bättig, Meinrad Mannhart

|Sep 08, 2016
A Mobile App to Stabilize Daily Functional Activity of Breast Cancer Patients in Collaboration With the Physician: A Randomized Controlled Clinical Trial.

Marco Egbring, Elmira Far, Malgorzata Roos

|Jul 28, 2016
HER2/CEP17 Ratios and Clinical Outcome in HER2-Positive Early Breast Cancer Undergoing Trastuzumab-Containing Therapy.

Albina Stocker, Marie-Luise Hilbers, Claire Gauthier

Pageof 1

Frequent Collaborators

3 joint publications

Gerd A Kullak-Ublick

2 joint publications

Marco Egbring

2 joint publications

Mathis N Brauchbar

2 joint publications

Johannes Schumacher